This is stated on the WHO Twitter page.

“We expect the results of two clinical trials of drugs,” his organization quotes.

"We're also looking forward to results from two clinical trials of therapeutics prioritized by the WHO R&D Blueprint.
One combines two drugs for HIV, lopinavir & ritonavir & the other is testing an antiviral called remdisivir.
We expect preliminary results in 3 weeks "- @ DrTedros

- World Health Organization (WHO) (@WHO) February 20, 2020

According to him, one of them is “a combination of two HIV drugs - lopinavir and ritonavir,” and the second is an “antiviral drug called remdivivir.”

“We expect preliminary results in three weeks,” he pointed out.

Earlier, an epidemiologist, senior researcher at the Russian Scientific and Methodological Center for the Prevention and Control of AIDS, Oleg Yurin, in an interview with NSN, assessed the situation with the spread of coronavirus.